World’s biggest insulin producer’s drug approved in Japan September 29, 2012 - 16:24 AMT PanARMENIAN.Net - Denmark's Novo Nordisk A/S, the world's biggest insulin producer, said on Friday its diabetes treatment Tresiba had been approved in Japan. Novo Nordisk said in a statement it expected to launch Tresiba in the country as soon as price negotiations have been completed, Reuters reported. Partner news  Top stories The bomber set off his explosives outside the gate of the United Nations Development Program base before attackers ran inside. Hamid Karzai accused Washington of mixed messages regarding peace talks with the Taliban, his spokesman said. The deal is estimated at $700mln-$1bln, Vedomosti newspaper reported citing sources in the Russian defense industry. Ahmadinejad will be replaced by Hassan Rowhani as president on August 3 following presidential elections last week.   Partner news |  Latest news Microsoft rumored to look into buying Nokia‘s handset business  The price tag and market position concerns weren’t the only reason the talks fell through, says the sources, without additional details.Megaupload files deleted, Dotcom decries ‘largest data massacre’ "We were never warned about the deletion," Dotcom said, adding that the loss of the files had reduced him to tears.LinkedIn suffers outage due to ‘DNS issue’ "We determined it was a DNS issue, we're continuing to work on it. Thanks for your patience,” the network tweeted."The Sopranos" star James Gandolfini dies at 51 "We're all in shock and feeling immeasurable sadness at the loss of a beloved member of our family," the network said. |
